From: Chemosensetizing and cardioprotective effects of resveratrol in doxorubicin- treated animals
Treatment | Mean survival time | 45-day survivors |
---|---|---|
Control | 15 ± 4.06 a, b | 0/10 |
RSVL (10 mg/kg) | 13 ± 3.55 b | 0/10 |
DOX (15 mg/kg) | 21 ± 9.19 a, b | 1/10 |
DOX (15 mg/kg) + RSVL (10 mg/kg) (supplied simultaneously) | 30 ± 5.29 a, b | 7/10 |